Zepp Health Corporation (ZEPP) Reports Q4 EPS of $0.30

Zepp Health Corporation (NYSE: ZEPP) reported Q4 EPS of $0.30, versus $0.48 reported last year. Revenue for the quarter came in at $303.3 million, versus $302.3 million reported last year.

Outlook:

For the first quarter of 2021, the management of the Company currently expects:

• - Net revenues to be between RMB1.0 billion and RMB1.15 billion, compared with RMB1.09 billion in the first quarter of 2020.
• The above outlook is based on the current market conditions and reflects the Company management's current and preliminary estimates of market and operating conditions and customer demand, which are all subject to change.

For earnings history and earnings-related data on Zepp Health Corporation (ZEPP) click here.

You May Also Be Interested In

• Gilead Sciences (GILD) Misses Q1 EPS by 288c
• MidWestOne Financial Group, Inc. (MOFG) Misses Q1 EPS by 15c
• Mohawk Industries (MHK) Tops Q1 EPS by 19c